Hospira Growth Aided By Drug Delivery Pump Sales, Up 19% Year-To-Date
This article was originally published in The Gray Sheet
Executive Summary
Hospira forecasts average drug delivery pump revenue growth of more than 19%, driven by increased adoption of advanced systems designed to reduce medication errors and regulatory difficulties encountered by competitor Baxter